Back to Trades
Stengone Carmine N.
CEO and PresidentDirectorCIK 0001861519
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 7
- Companies
- 2
- Active
- 2026
Across 8 filings between 2026, Stengone Carmine N., CEO and President, Director, has disclosed $6.9M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $401.4K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Sep 8 | CTNM Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO and President, Director | Sell | $41.1K |
| Aug 3 | CTNM Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO and President, Director | Sell | $40.0K |
| Jul 8 | CTNM Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO and President, Director | Sell | $40.0K |
| Jul 1 | CTNM Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO and President, Director | Sell | $160.1K |
| Jun 12 | KPRX KIORA PHARMACEUTICALS INC | Stengone Carmine N. | Director | Award | $65.8K |
| Feb 26 | CTNM Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO and President, Director | Sell | $113.7K |
| Feb 13 | CTNM Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO and President, Director | Sell | $6.4K |
| Jan 30 | CTNM Contineum Therapeutics, Inc. | Stengone Carmine N. | CEO and President, Director | Award | $6.3M |
8 filings